MAPT and Alzheimer disease: Future research integrating advanced tau biomarkers and multimodal imaging, alongside pathological validation, could refine our understanding of the molecular underpinnings of hippocampal atrophy and strengthen the clinical utility of 7T MRI in early AD detection and monitoring.